Ross River virus vaccine available soon

Clinical Professor David Smith from the University of Western Australia told the ARA conference that a phase three trial had been completed and the vaccine, manufactured by Baxter, was expected to be available in the “next few months”.

Rates of the mosquito-borne infection have remained at 4000 to 6000 a year in Australia over the past decade. It occurs throughout the country, particularly during the wet season in northern subtropical areas, and during late spring and early summer in the southern half of the